Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)
Clinical trial NCT05415410 · TERMINATED
Trial details
- NCT number
- NCT05415410
- Sponsor
- VectivBio AG
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2024-12-17
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.